Volume 1 Number 1
Previous issues
Editorials
Translational research in the new era of percutaneous mitral valve interventions
REC Interv Cardiol. 2021;3:1-2
Elderly patients with comorbidities and acute coronary syndrome: ¿primum non nocere?
REC Interv Cardiol. 2021;3:3-4
Virtual vs face-to-face meetings. Can both of them coexist?
REC Interv Cardiol. 2021;3:5-7
Original Articles
Experimental model of mitral regurgitation in a porcine model
REC Interv Cardiol. 2021;3:8-14
Impact of comorbidities in the decision of using invasive management in elderly patients with NSTEACS
REC Interv Cardiol. 2021;3:15-20
Microalbuminuria predicts contrast-induced nephropathy in patients with acute coronary syndrome
REC Interv Cardiol. 2021;3:21-25
Use of subcutaneous nitroglycerin to facilitate transradial access in coronary procedures (NiSAR Study)
REC Interv Cardiol. 2021;3:26-32
Special article
Update on requirements and equipment in interventional cardiology. Consensus document by the Interventional Cardiology Association and the Ischemic Heart Disease and Acute Cardiac Care Association of the Spanish Society of Cardiology and the Spanish Association of Nursing in Cardiology
REC Interv Cardiol. 2021;3:33-44
Review Article
Left main coronary artery percutaneous revascularization: alea jacta est
REC Interv Cardiol. 2021;3:45-54
Debate
Debate: Refractory angina. The Reducer device as a new therapeutic approach. Perspective from the clinic
REC Interv Cardiol. 2021;3:59-61
Debate: Refractory angina. The Reducer device as a new therapeurefractic approach. Perspective from interventional cardiology
REC Interv Cardiol. 2021;3:62-64
Clinical Case
Percutaneous management of recurrent prosthetic valve thrombosis
REC Interv Cardiol. 2021;3:73-74
Percutaneous management of recurrent prosthetic valve thrombosis. How would I approach it?
REC Interv Cardiol. 2021;3:74-75
Percutaneous management of recurrent prosthetic valve thrombosis. Case resolution
REC Interv Cardiol. 2021;3:75-77
Review Article
Cerebral embolic protection device in TAVI after the REFLECT II clinical trial: does it change our strategy?
REC Interv Cardiol. 2021;3:55-58
Images in cardiology
Left main coronary artery perforation after rotational atherectomy
REC Interv Cardiol. 2021;3:78-79
Deployment of cerebral protection device in complex anatomy
REC Interv Cardiol. 2021;3:80-81
Magmaris bioresorbable stent: cardiac CT follow-up
REC Interv Cardiol. 2021;3:82
Scientific letters
Cardiovascular interventions live: show or training? The professional perspective: the LIVE study
REC Interv Cardiol. 2021;3:65-66
Anomalous origin of left circumflex artery from the right pulmonary artery of an adult
REC Interv Cardiol. 2021;3:67-69
Transcatheter aortic valve migration in aortic regurgitation following left ventricular assist device
REC Interv Cardiol. 2021;3:69-71
Effects of the COVID-19 pandemic on the population over 75 years old with coronary artery disease. The EPIC SIERRA 75 registry
REC Interv Cardiol. 2021;3:71-72
Congresses abstracts
Previous issues

Editor's page
The first two years of REC: Interventional Cardiology
REC Interv Cardiol. 2020;2:233-238
Editorials
Spontaneous coronary artery dissection: new insights on diagnosis and management
REC Interv Cardiol. 2020;2:239-241
Routine endomyocardial biopsy in heart transplantation: in search of lost evidence
REC Interv Cardiol. 2020;2:242-243
Use of cangrelor in percutaneous coronary interventions: a “new” weapon in the antithrombotic therapeutic armamentarium
REC Interv Cardiol. 2020;2:244-246
Original Articles
Contemporary management of spontaneous coronary dissection
REC Interv Cardiol. 2020;2:247-255
Rotational atherectomy for the management of bifurcation lesions: a pilot randomized study
REC Interv Cardiol. 2020;2:256-263
Endomyocardial biopsy using the brachial venous access route. Description of the technique and 12-year experience at 2 different centers
REC Interv Cardiol. 2020;2:264-271
Value of the optical coherence tomography in the diagnosis of unstable patients with non-significant coronary stenosis
REC Interv Cardiol. 2020;2:272-279
Review Article
Left ventricular assist devices in acute cardiovascular care patients and high-risk percutaneous coronary interventions
REC Interv Cardiol. 2020;2:280-287
Debate
Debate: Intravascular ultrasound and optical coherence tomography in percutaneous revascularization. The IVUS expert perspective
REC Interv Cardiol. 2020;2:288-290
Debate: Intravascular ultrasound and optical coherence tomography in percutaneous revascularization. The OCT expert perspective
REC Interv Cardiol. 2020;2:291-293
Clinical Case
Embolization of pseudoaneurysm in Dacron subclavian-aortic graft for interrupted aortic arch repair
REC Interv Cardiol. 2020;2:294
Impella-Clip: a secure and effective strategy in cardiogenic shock due to acute severe mitral regurgitation. How would I approach it?
REC Interv Cardiol. 2023;5:313-314
Embolization of pseudoaneurysm in Dacron subclavian-aortic graft for interrupted aortic arch repair. How would I approach it?
REC Interv Cardiol. 2020;2:295-296
Embolization of pseudoaneurysm in Dacron subclavian-aortic graft for interrupted aortic arch repair. Case resolution
REC Interv Cardiol. 2020;2:296-297
Review Article
The POPular TAVI trial. Antithrombotic therapy following TAVI: towards a minimalist strategy
REC Interv Cardiol. 2020;2:298-301
Images in cardiology
Calcified plaques in the radial artery: OCT insight
REC Interv Cardiol. 2020;2:302-303
Alternative approach to advance the Impella CP device
REC Interv Cardiol. 2020;2:304-305
Scientific letters
ISCHEMIA trial: a win for the optimal medical therapy in the management of stable coronary artery disease?
REC Interv Cardiol. 2020;2:306-307
Temporal relation between invasively managed acute coronary syndromes and confinement during the current COVID-19 pandemic
REC Interv Cardiol. 2020;2:307-309
Impact of the COVID-19 pandemic on transcatheter aortic valve implantation in Spain
REC Interv Cardiol. 2020;2:310-312
Percutaneous extracorporeal membrane oxygenation during the COVID-19 pandemic. A Spanish multicenter registry
REC Interv Cardiol. 2020;2:312-314
Congresses abstracts
Previous issues
Editorials
Transcatheter mitral valve replacement: there is no one-size-fits-all solution
REC Interv Cardiol. 2020;2:161-162
Drug-coated balloon catheters. Discussing mortality from the coronary perspective
REC Interv Cardiol. 2020;2:163-165
Scientific debates among professionals in social media: a fantastic, but not risk-free scenario
REC Interv Cardiol. 2020;2:166-167
Original Articles
Bioresorbable vascular scaffolds in the routine clinical practice: long-term results
REC Interv Cardiol. 2020;2:168-174
Pharmacoinvasive strategy as reperfusion treatment in non-capable primary percutaneous coronary intervention areas
REC Interv Cardiol. 2020;2:175-182
Fifteen years of percutaneous coronary interventions for chronic total coronary occlusions. Experience, results, and clinical outcomes
REC Interv Cardiol. 2020;2:183-190
Single low-dose of apixaban in patients with atrial fibrillation after transcatheter aortic valve implantation
REC Interv Cardiol. 2020;2:191-198
Review Article
Specific indications for TAVI
REC Interv Cardiol. 2020;2:206-214
Debate
Debate: Mechanical circulatory support in relation to coronary intervention. The interventional cardiologist perspective
REC Interv Cardiol. 2020;2:215-216
Debate: Mechanical circulatory support in relation to coronary intervention. Cardiologist’s perspective from the cardiac intensive care unit
REC Interv Cardiol. 2020;2:217-218
Clinical Case
Bail-out alcohol septal ablation in the management of obstructive hypertrophic cardiomyopathy and refractory electrical storm
REC Interv Cardiol. 2020;2:219-220
Images in cardiology
Pulmonary arteriovenous fistula as a possible cause for myocardial infarction
REC Interv Cardiol. 2020;2:224-225
Percutaneous reconstruction of pulmonary trunk to solve stent embolization
REC Interv Cardiol. 2020;2:226-227
Scientific letters
Use of radial access to create an arterio-arterial loop to facilitate the percutaneous closure of paravalvular aortic leak. Is it feasible?
REC Interv Cardiol. 2020;2:228-229
Transcatheter aortic valve implantation during the current COVID-19 pandemic. Recommendations from the ACI-SEC
REC Interv Cardiol. 2020;2:230-231
Interviews
An interview with Bruno Scheller
aServicio de Cardiología, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa (IIS-IP), Universidad Autónoma de Madrid, Spain
bCentro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain


